| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA
CORRESPONDENCE: M.A. Matthay, Cardiovascular Research Institute, 505 Parnassus Avenue, HSW-825, University of California San Francisco, San Francisco, CA, 94143-0130, USA
Keywords: acute respiratory distress syndrome, ß2-adrenergic agonists, alveolar fluid clearance, pulmonary oedema
Received: March 18, 2002
Accepted April 16, 2002
Abstract
Pulmonary oedema is a life-threatening condition that frequently leads to acute respiratory failure. From a physiological perspective, pulmonary oedema develops either because of an increase in lung vascular hydrostatic pressure or an increase in lung vascular permeability. Resolution of alveolar oedema depends on the active removal of salt and water from the distal air spaces of the lung across the distal lung epithelial barrier.
Much has been learned about the molecular and cellular basis for oedema fluid reabsorption, including the role of apical ion transporters for sodium (epithelial sodium channel) and chloride (cystic fibrosis transmembrane conductance regulator), as well as the central importance of the sodium pump. The rate of fluid clearance can be upregulated by both catecholamine-dependent and -independent mechanisms.
Injury to the alveolar epithelium can disrupt the integrity of the alveolar barrier or downregulate ion transport pathways, thus, reducing net alveolar fluid reabsorption and enhancing the extent of alveolar oedema. Endogenous catecholamines upregulate alveolar fluid clearance in several experimental models of acute lung injury, but this upregulation may be short term and insufficient to counterbalance alveolar flooding. There is new evidence, however, that pharmacological treatment with ß2-adrenergic agonists and/or epithelial growth factors may influence a more sustained stimulation of alveolar fluid reabsorption and in turn facilitate recovery from experimental pulmonary oedema. Similar results have been achieved experimentally by gene transfer to enhance the abundance of sodium transporters in the alveolar epithelium.
Clinical studies show that impaired alveolar fluid transport mechanisms contribute to the development, severity and outcome of pulmonary oedema in humans. Very recent data suggest that mechanisms that augment transepithelial sodium transport and enhance the clearance of alveolar oedema may lead to more effective prevention or treatment for some types of pulmonary oedema.
This article has been cited by other articles:
|
|
 |
|
  I. A. Kolosova, T. Mirzapoiazova, L. Moreno-Vinasco, S. Sammani, J. G. N. Garcia, and A. D. Verin Protective effect of purinergic agonist ATP{gamma}S against acute lung injury Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L319 - L324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xu, T. J. Ferro, and S. Chu Cigarette smoke condensate inhibits ENaC {alpha}-subunit expression in lung epithelial cells Eur. Respir. J., October 1, 2007; 30(4): 633 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C-F. Su, D. D. Liu, S. J. Kao, and H. I. Chen Nicotinamide abrogates acute lung injury caused by ischaemia/reperfusion Eur. Respir. J., August 1, 2007; 30(2): 199 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Andrade, A. C. Rodrigues Jr., T. R. C. Sanches, R. B. Souza, and A. C. Seguro Leptospirosis leads to dysregulation of sodium transporters in the kidney and lung Am J Physiol Renal Physiol, February 1, 2007; 292(2): F586 - F592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dagenais, R. Frechette, M.-E. Clermont, C. Masse, A. Prive, E. Brochiero, and Y. Berthiaume Dexamethasone inhibits the action of TNF on ENaC expression and activity Am J Physiol Lung Cell Mol Physiol, December 1, 2006; 291(6): L1220 - L1231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ikegami, K. Carter, K. Bishop, A. Yadav, E. Masterjohn, W. Brondyk, R. K. Scheule, and J. A. Whitsett Intratracheal Recombinant Surfactant Protein D Prevents Endotoxin Shock in the Newborn Preterm Lamb Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1342 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Helms, X.-J. Chen, S. Ramosevac, D. C. Eaton, and L. Jain Dopamine regulation of amiloride-sensitive sodium channels in lung cells Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L710 - L722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. C. Davis, E. R. Lazarowski, J. M. Hickman-Davis, J. A. Fortenberry, F.-P. Chen, X. Zhao, E. Sorscher, L. M. Graves, W. M. Sullender, and S. Matalon Leflunomide Prevents Alveolar Fluid Clearance Inhibition by Respiratory Syncytial Virus Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 673 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Perkins, D. F. McAuley, D. R. Thickett, and F. Gao The beta-Agonist Lung Injury Trial (BALTI): A Randomized Placebo-controlled Clinical Trial Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 281 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Looney, C. Sartori, S. Chakraborty, P. F. James, J. B. Lingrel, and M. A. Matthay Decreased expression of both the {alpha}1- and {alpha}2-subunits of the Na-K-ATPase reduces maximal alveolar epithelial fluid clearance Am J Physiol Lung Cell Mol Physiol, July 1, 2005; 289(1): L104 - L110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sartori, H. Duplain, M. Lepori, M. Egli, M. Maggiorini, P. Nicod, and U. Scherrer High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects Eur. Respir. J., June 1, 2004; 23(6): 916 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Berthiaume Tumor Necrosis Factor and Lung Edema Clearance: The Tip of the Iceberg? Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1022 - 1023. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
